MENU
+Compare
CNS
Stock ticker: NYSE
AS OF
Jan 30, 04:59 PM (EDT)
Price
$88.78
Change
+$0.34 (+0.38%)
Capitalization
3.7B

CNS Cohen & Steers Forecast, Technical & Fundamental Analysis

a company which specializes in assets and capital management and investment services

CNS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for CNS with price predictions
Jan 29, 2025

CNS in upward trend: price may jump up because it broke its lower Bollinger Band on January 10, 2025

CNS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 38 cases where CNS's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where CNS's RSI Indicator exited the oversold zone, of 23 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on January 27, 2025. You may want to consider a long position or call options on CNS as a result. In of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CNS just turned positive on January 21, 2025. Looking at past instances where CNS's MACD turned positive, the stock continued to rise in of 41 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CNS advanced for three days, in of 318 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CNS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for CNS entered a downward trend on January 23, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock slightly better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CNS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.709) is normal, around the industry mean (2.769). P/E Ratio (28.735) is within average values for comparable stocks, (27.127). Projected Growth (PEG Ratio) (4.903) is also within normal values, averaging (3.172). Dividend Yield (0.031) settles around the average of (0.073) among similar stocks. P/S Ratio (7.559) is also within normal values, averaging (11.501).

View a ticker or compare two or three
CNS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

CNS is expected to report earnings to fall 3.45% to 75 cents per share on April 16

Cohen & Steers CNS Stock Earnings Reports
Q1'25
Est.
$0.75
Q4'24
Missed
by $0.02
Q3'24
Beat
by $0.03
Q2'24
Beat
by $0.01
Q1'24
Missed
by $0.02
The last earnings report on January 22 showed earnings per share of 77 cents, missing the estimate of 80 cents. With 160.65K shares outstanding, the current market capitalization sits at 3.70B.
A.I.Advisor
published Dividends

CNS paid dividends on December 02, 2024

Cohen & Steers CNS Stock Dividends
А dividend of $0.59 per share was paid with a record date of December 02, 2024, and an ex-dividend date of November 18, 2024. Read more...
A.I. Advisor
published General Information

General Information

a company which specializes in assets and capital management and investment services

Industry InvestmentManagers

Profile
Fundamentals
Details
Industry
Investment Managers
Address
1166 Avenue of the Americas
Phone
+1 212 832-3232
Employees
405
Web
https://www.cohenandsteers.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
APSLX17.300.15
+0.87%
NYLI Fiera SMID Growth Class C
RWMGX64.240.49
+0.77%
American Funds Washington Mutual R6
FACDX58.81N/A
N/A
Fidelity Advisor Health Care A
SMNIX27.43N/A
N/A
Steward Equity Market Neutral I
GSUTX62.63N/A
N/A
Goldman Sachs US Equity Insights Inv

CNS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CNS has been closely correlated with APAM. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if CNS jumps, then APAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNS
1D Price
Change %
CNS100%
+0.44%
APAM - CNS
68%
Closely correlated
+1.23%
APO - CNS
64%
Loosely correlated
+0.39%
VRTS - CNS
62%
Loosely correlated
+1.12%
JHG - CNS
61%
Loosely correlated
+0.90%
BX - CNS
60%
Loosely correlated
-4.10%
More

Groups containing CNS

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNS
1D Price
Change %
CNS100%
+0.44%
CNS
(2 stocks)
97%
Closely correlated
+0.83%